Compare Phyto Chem (I) with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -27.20% and Operating profit at -207.52% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 2.33 times
- The company has been able to generate a Return on Equity (avg) of 1.88% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pesticides & Agrochemicals
INR 12 Cr (Micro Cap)
NA (Loss Making)
30
0.00%
2.75
-12.69%
2.22
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-25-2014
Risk Adjusted Returns v/s 
Returns Beta
News

Phyto Chem (India) Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
Phyto Chem (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 Jan 2026, driven primarily by a shift in technical indicators signalling a mildly bullish trend. However, the company’s fundamental and valuation metrics remain weak, reflecting ongoing operational challenges and poor long-term financial performance within the pesticides and agrochemicals sector.
Read full news article
Phyto Chem (India) Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Technical Deterioration
Phyto Chem (India) Ltd, a player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 January 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risks for investors amid ongoing operational challenges and market underperformance.
Read full news article
Phyto Chem (India) Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Phyto Chem (India), a player in the Pesticides & Agrochemicals sector, has experienced a revision in its market assessment driven primarily by changes in technical indicators, while its fundamental financial metrics continue to reflect challenges. This article analyses the recent shifts across quality, valuation, financial trends, and technical parameters to provide a comprehensive view of the company’s current standing.
Read full news article Announcements 
Closure of Trading Window
31-Dec-2025 | Source : BSEWe wish to inform you that in accordance with the Code of Conduct for Prevention of Insider Trading devised by the Company as per the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the shares of the Company will be closed to all the Directors Key Managerial Personnel and all designated persons of the Company with effect from 1st January 2026 till 48 hours after the declaration of Quarterly Unaudited Financial Results of the Company for the Third Quarter ended on 31st December 2025. The date of Board meeting for the consideration of Unaudited Financial Results of the Company for the Third Quarter ended on 31st December 2025 shall be intimated in due course of time.
Results-Financial Results For SEP 30 2025 (Submission Of Unaudited Financial Results Of The Company For The Second Quarter And Half-Year Ended 30Th September 2025 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations 2015-Regarding
14-Nov-2025 | Source : BSEIn furtherance to the Board meeting notice dated 06-11-2025 we wish inform you that at the meeting of Board of Directors of M/s.Phyto Chem (India) Limited held today i.e. on 14-11-2025 the Board has inter-alia considered and approved the unaudited financial results for the second quarter and half year ended 30-09-2025. The said unaudited financial results were reviewed by the audit committee and their after approved by the Board. Pursuat Regulation 33 of the SEBI(LODR) Regulations 2015 statement showing the unaudited financial results for the second quarter and half year ended on 30-09-2025 along with limited review report issued by the statutory auditors is attached herewith. The meeting commenced at 04:00PM and concluded at 08:15PM.
Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Regarding
14-Nov-2025 | Source : BSEPursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 14th November 2025 the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the Second Quarter and half- year ended 30th September 2025. The meeting commenced at 04:00 P.M. and concluded at 08:15 P.M. This is for your information and record.
Corporate Actions 
No Upcoming Board Meetings
Phyto Chem (India) Ltd has declared 10% dividend, ex-date: 25 Sep 14
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 2 Schemes (0.19%)
Held by 0 FIIs
Nayudamma Yarlagadda (7.87%)
Andhra Pradesh Industrial Development Corporation Limited (4.63%)
49.36%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is -0.23% vs -39.39% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -609.09% vs 168.75% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024
Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -12.11% vs -33.96% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 109.82% vs -1,730.00% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -4.93% vs -44.66% in Mar 2024
YoY Growth in year ended Mar 2025 is 70.27% vs -1,613.64% in Mar 2024






